These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33428478)

  • 1. Manganese and copper levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
    Dastych M; Husová L; Aiglová K; Fejfar T; Dastych M
    Scand J Clin Lab Invest; 2021 Apr; 81(2):116-120. PubMed ID: 33428478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitis.
    Kowdley KV; Knox TA; Kaplan MM
    Dig Dis Sci; 1994 Nov; 39(11):2416-20. PubMed ID: 7956610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
    Franco J; Saeian K
    Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.
    Bell LN; Wulff J; Comerford M; Vuppalanchi R; Chalasani N
    Liver Int; 2015 Jan; 35(1):263-74. PubMed ID: 25181933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis].
    Fejfar T; Vaňásek T; Hůlek P
    Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.
    Gallucci GM; Trottier J; Hemme C; Assis DN; Boyer JL; Barbier O; Ghonem NS
    Hepatol Commun; 2021 Dec; 5(12):2035-2051. PubMed ID: 34558841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary biliary cirrhosis and primary sclerosing cholangitis.
    Angulo P; Lindor KD
    Clin Liver Dis; 1999 Aug; 3(3):529-70. PubMed ID: 11291238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholestatic liver diseases].
    Grimm D; Thimme R
    Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis.
    ter Borg PC; Fekkes D; Vrolijk JM; van Buuren HR
    BMC Gastroenterol; 2005 Mar; 5():11. PubMed ID: 15790420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
    Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
    J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of overlap syndromes.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2015 Feb; 19(1):81-97. PubMed ID: 25454298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis.
    Karlsen TH; Vesterhus M; Boberg KM
    Aliment Pharmacol Ther; 2014 Feb; 39(3):282-301. PubMed ID: 24372568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
    Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
    Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
    Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
    Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis and primary biliary cirrhosis. How effective is medical therapy?
    Fennerty MB
    Postgrad Med; 1993 Nov; 94(6):81-8; 92. PubMed ID: 8234100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
    Ahn DW
    Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW
    Semin Liver Dis; 2000; 20(4):481-95. PubMed ID: 11200417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTHRC1 expression in primary biliary cholangitis.
    Li YK; Li YM; Li Y; Wei YR; Zhang J; Li B; You ZR; Chen Y; Huang BY; Miao Q; Wang QX; Peng YS; Gershwin ME; Tang RQ; Bian ZL; Ma X
    J Dig Dis; 2019 Jul; 20(7):371-376. PubMed ID: 31102333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.